FDA Approved: TRI-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TRI-SPRINTEC (norgestimate and ethinyl estradiol) submitted by Teva Pharmaceuticals USA, Inc., resulting in updated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Prevention

Drugs mentioned

• TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)